Nigel B Jamieson

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

J. Quinn, A. Roseweir, C. Steele, 2024, Journal of experimental & clinical cancer research : CR.

Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy

D. Calvisi, J. Llovet, C. Braconi, 2023, Gut.

Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups

A. Pea, G. Nappo, Marialuisa Barbagallo, 2024, Frontiers in oncology.